ranitidine has been researched along with Colorectal Neoplasms in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 6 (50.00) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Hamada, S; Ishimaru, M; Ito, Y; Iwagami, M; Kumazawa, R; Miyamoto, Y; Morita, K; Tamiya, N; Yasunaga, H | 1 |
| Au, KH; Chan, WL; Choy, TS; Leung, TW; Liu, KY; Siu, SW | 1 |
| Deva, S; Jameson, M | 1 |
| Hamaguchi, T; Hashimoto, H; Iwasa, S; Kato, K; Shimada, Y; Yamada, Y; Yamamoto, H; Yanai, T | 1 |
| Christensen, IJ; Kehlet, H; Moesgaard, F; Nielsen, HJ | 1 |
| Arumugam, PJ; Beynon, J; Hirst, G | 1 |
| Christensen, IJ; Christiansen, J; Flyger, H; Larsen, JK; Post, C | 1 |
| Kumar, P; Mulcahy, H; Patchett, S; Rajendra, S | 1 |
| Hammer, JH; Moesgaard, F; Nielsen, HJ | 1 |
| Kawabe, T; Kobayashi, K; Matsumoto, S; Morishima, T; Okamoto, T | 1 |
| Brünner, N; Christensen, IJ; Moesgaard, F; Nielsen, HJ; Sørensen, S | 1 |
| Hamblin, TJ | 1 |
1 review(s) available for ranitidine and Colorectal Neoplasms
| Article | Year |
|---|---|
Histamine type 2 receptor antagonists as adjuvant treatment for resected colorectal cancer.
Topics: Antineoplastic Agents; Chemotherapy, Adjuvant; Cimetidine; Colorectal Neoplasms; Histamine H2 Antagonists; Humans; Randomized Controlled Trials as Topic; Ranitidine | 2012 |
4 trial(s) available for ranitidine and Colorectal Neoplasms
| Article | Year |
|---|---|
Ranitidine as adjuvant treatment in colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Chemotherapy, Adjuvant; Colorectal Neoplasms; Double-Blind Method; Female; Histamine H2 Antagonists; Humans; Infusions, Intravenous; Male; Middle Aged; Multivariate Analysis; Preoperative Care; Ranitidine; Survival Analysis | 2002 |
Flow cytometric bivariate analysis of DNA and cytokeratin in colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Aneuploidy; Anti-Ulcer Agents; Biopsy; Colorectal Neoplasms; DNA, Neoplasm; Female; Flow Cytometry; Humans; Keratins; Male; Middle Aged; Prognosis; Prospective Studies; Ranitidine; Reproducibility of Results; S Phase; Survival Analysis | 2002 |
Preoperative plasma plasminogen activator inhibitor type-1 and serum C-reactive protein levels in patients with colorectal cancer. The RANX05 Colorectal Cancer Study Group.
Topics: Adult; Aged; Aged, 80 and over; C-Reactive Protein; Colorectal Neoplasms; Data Interpretation, Statistical; Double-Blind Method; Follow-Up Studies; Histamine H2 Antagonists; Humans; Middle Aged; Plasminogen Activator Inhibitor 1; Preoperative Care; Prognosis; Ranitidine; Survival Analysis | 2000 |
Indomethacin, ranitidine, and interleukin-2 in melanoma.
Topics: Colorectal Neoplasms; Drug Therapy, Combination; Humans; Indomethacin; Interleukin-2; Kidney Neoplasms; Melanoma; Ranitidine | 1992 |
7 other study(ies) available for ranitidine and Colorectal Neoplasms
| Article | Year |
|---|---|
Risk of Cancer in Association with Ranitidine and Nizatidine vs Other H2 Blockers: Analysis of the Japan Medical Data Center Claims Database 2005-2018.
Topics: Adult; Aged; Colorectal Neoplasms; Female; Histamine H2 Antagonists; Humans; Japan; Male; Middle Aged; Nizatidine; Ranitidine | 2021 |
Re-challenging patients with oxaliplatin allergy: the successful use of a standardised pre-medication protocol in a single institute.
Topics: Adult; Aged; Anaphylaxis; Anesthetics, Local; Anti-Inflammatory Agents; Antineoplastic Agents; Colorectal Neoplasms; Dexamethasone; Diphenhydramine; Drug Hypersensitivity; Female; Histamine H2 Antagonists; Humans; Injections, Intravenous; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Premedication; Ranitidine; Treatment Outcome | 2011 |
Successful rechallenge for oxaliplatin hypersensitivity reactions in patients with metastatic colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Chlorpheniramine; Colorectal Neoplasms; Drug Hypersensitivity; Epinephrine; Female; Humans; Hydrocortisone; Male; Middle Aged; Neoplasm Metastasis; Organoplatinum Compounds; Oxaliplatin; Ranitidine; Retrospective Studies | 2012 |
Ranitidine as adjuvant treatment in colorectal cancer (Br J Surg 2002; 89: 1416-1422).
Topics: Anti-Ulcer Agents; Cause of Death; Chemotherapy, Adjuvant; Colorectal Neoplasms; Diathermy; Humans; Ranitidine | 2003 |
The effect of H2 antagonists on proliferation and apoptosis in human colorectal cancer cell lines.
Topics: Adenocarcinoma; Apoptosis; Caco-2 Cells; Cell Line, Tumor; Cell Proliferation; Cimetidine; Colorectal Neoplasms; Colorimetry; Drug Combinations; Histamine; Histamine H2 Antagonists; Humans; In Vitro Techniques; Ranitidine | 2004 |
Effect of ranitidine and low-dose interleukin-2 in vitro on NK-cell activity in peripheral blood from patients with liver metastases from colorectal cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Synergism; Histamine H2 Antagonists; Humans; In Vitro Techniques; Interleukin-2; Killer Cells, Natural; Liver Neoplasms; Ranitidine; Recombinant Proteins | 1995 |
Cimetidine inhibits cancer cell adhesion to endothelial cells and prevents metastasis by blocking E-selectin expression.
Topics: Animals; Cell Adhesion; Cell Nucleus; Cimetidine; Colorectal Neoplasms; Dose-Response Relationship, Drug; Down-Regulation; E-Selectin; Endothelium, Vascular; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Famotidine; Histamine H2 Antagonists; Humans; Interleukin-1; Liver Neoplasms; Mice; Mice, Nude; Microscopy, Confocal; Neoplasm Transplantation; NF-kappa B; Oligosaccharides; Ranitidine; RNA, Messenger; Sialyl Lewis X Antigen; Transcriptional Activation; Tumor Cells, Cultured; Umbilical Veins | 2000 |